Eris Lifesciences acquires Strides Shasun's India branded generics biz for $77m

Eris Lifesciences acquires Strides Shasun's India branded generics biz for $77m

Ishita Russell

20 November, 2017

acquisitionEris Lifesciences LtdpharmaStrides Shasun Ltd

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.